TaqMan® PCR experiments performed for two of these molecules, CDH13 and PLAU, corroborated array results revealing significant expression levels differences between the two cancer types, not only in the cell lines, but also in an additional set of primary 14 PDTC and three ATC. The gene discussed is PLAU; the disease is cancer.